AstraZeneca agreed Tuesday to pay $5.5 million in penalties and interest to settle claims that it violated the Foreign Corrupt Practices Act through improper payments to health care providers in China and Russia.
August 31, 2016 at 11:00 PM
1 minute read
AstraZeneca agreed Tuesday to pay $5.5 million in penalties and interest to settle claims that it violated the Foreign Corrupt Practices Act through improper payments to health care providers in China and Russia.
The U.S. Securities and Exchange Commission alleged the London-based company used cash and gifts to persuade health care providers to buy or prescribe certain drugs. The agency issued a cease and desist order. The company neither admitted nor denied the findings.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
Predictive reporting, trend analysis, peer guidance and a practical playbook to help genetal counsels succeed in their increasingly high stakes roles as risk managers and corporate strategists
